Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Whitehurst

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Urology|May 1, 1994
In vivo laser light distribution in human prostatic carcinomaC Whitehurst, M L Pantelides, J V Moore, et al.
Msphere|February 14, 2018
C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to ExosomesE Kobayashi, M Aga, S Kondo, et al.
Lancet (London, England)|May 21, 1998
Photodynamic treatment for lower genital tract intraepithelial neoplasiaP L Martin-Hirsch, C Whitehurst, C H Buckley, et al.
British Journal of Urology|January 24, 1998
Interstitial photodynamic therapy in the canine prostateL K Lee, C Whitehurst, Q Chen, et al.
The British Journal of Dermatology|November 1, 1996
Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's diseaseC A Morton, C Whitehurst, H Moseley, et al.
SLAS Discovery : Advancing Life Sciences R & D|January 26, 2024
Covalent hits and where to find themSimon C C Lucas, J Henry Blackwell, Sarah H Hewitt, et al.
BJU International|November 9, 2000
Light penetration in bladder tissue: implications for the intravesical photodynamic therapy of bladder tumoursD C Shackley, C Whitehurst, J V Moore, et al.
Journal of Medicinal Chemistry|May 24, 2023
Design and Evaluation of a Low Hydrogen Bond Donor Count Fragment Screening Set to Aid Hit Generation of PROTACs Intended for Oral DeliveryBenjamin C Whitehurst, Matthias R Bauer, Fredrik Edfeldt, et al.
BJU International|December 4, 2002
Comparison of the cellular molecular stress responses after treatments used in bladder cancerD C Shackley, A Haylett, C Whitehurst, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2020
Identification of 2-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)amino)-N-phenylpropanamides as a novel class of potent DprE1 inhibitorsBenjamin C Whitehurst, Robert J Young, Glenn A Burley, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Urology|May 1, 1994
In vivo laser light distribution in human prostatic carcinomaC Whitehurst, M L Pantelides, J V Moore, et al.
Msphere|February 14, 2018
C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to ExosomesE Kobayashi, M Aga, S Kondo, et al.
Lancet (London, England)|May 21, 1998
Photodynamic treatment for lower genital tract intraepithelial neoplasiaP L Martin-Hirsch, C Whitehurst, C H Buckley, et al.
British Journal of Urology|January 24, 1998
Interstitial photodynamic therapy in the canine prostateL K Lee, C Whitehurst, Q Chen, et al.
The British Journal of Dermatology|November 1, 1996
Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's diseaseC A Morton, C Whitehurst, H Moseley, et al.
SLAS Discovery : Advancing Life Sciences R & D|January 26, 2024
Covalent hits and where to find themSimon C C Lucas, J Henry Blackwell, Sarah H Hewitt, et al.
BJU International|November 9, 2000
Light penetration in bladder tissue: implications for the intravesical photodynamic therapy of bladder tumoursD C Shackley, C Whitehurst, J V Moore, et al.
Journal of Medicinal Chemistry|May 24, 2023
Design and Evaluation of a Low Hydrogen Bond Donor Count Fragment Screening Set to Aid Hit Generation of PROTACs Intended for Oral DeliveryBenjamin C Whitehurst, Matthias R Bauer, Fredrik Edfeldt, et al.
BJU International|December 4, 2002
Comparison of the cellular molecular stress responses after treatments used in bladder cancerD C Shackley, A Haylett, C Whitehurst, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2020
Identification of 2-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)amino)-N-phenylpropanamides as a novel class of potent DprE1 inhibitorsBenjamin C Whitehurst, Robert J Young, Glenn A Burley, et al.
Pageof 5